- $1.40bn
- $1.14bn
- $76.30m
- 55
- 20
- 99
- 61
Annual balance sheet for Zymeworks, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 426 | 253 | 492 | 374 | 226 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 15.3 | 15.6 | 33.4 | 19.5 | 55.8 |
| Prepaid Expenses | |||||
| Total Current Assets | 455 | 288 | 545 | 413 | 300 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17.6 | 49.8 | 47.6 | 37.5 | 34.3 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 538 | 389 | 649 | 581 | 463 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 85.7 | 71.9 | 95.6 | 55.8 | 88.3 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 128 | 140 | 156 | 116 | 124 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 410 | 249 | 493 | 465 | 339 |
| Total Liabilities & Shareholders' Equity | 538 | 389 | 649 | 581 | 463 |
| Total Common Shares Outstanding |